Tumor tímico

Girard N, Ruffini E, Marx A, et al. Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(suppl 5):v40-v55.Texto completo  Resumo

Phan AT, Öberg K, Choi J, et al. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus). Pancreas. 2010;39:784-98.Texto completo  Resumo

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: thymomas and thymic carcinomas [internet publication].Texto completo

1. Hsu CH, Chan JK, Yin CH, et al. Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States. PLoS One. 2019;14(12):e0227197.Texto completo  Resumo

2. Girard N, Ruffini E, Marx A, et al. Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(suppl 5):v40-v55.Texto completo  Resumo

3. Detterbeck FC. Clinical value of the WHO classification system of thymoma. Ann Thorac Surg. 2006;81:2328-34.Texto completo  Resumo

4. Shimosato Y, Mukai K. Tumors of the mediastinum. In: Rosai J, Sobin LH, eds. Atlas of tumor pathology. Washington, DC: Armed Forces Institute of Pathology; 1997:93-115.

5. Travis W, Brambilla E, Burke A, et al. Tumours of the thymus. In: WHO classification of tumours of the lung, pleura, thymus and heart. 4th ed. Lyon, France: IARC Press; 2015:184-298.

6. Marx A, Chan JKC, Chalabreysse L, et al. The 2021 WHO classification of tumors of the thymus and mediastinum: what Is new in thymic epithelial, germ cell, and mesenchymal tumors? J Thorac Oncol. 2022 Feb;17(2):200-13.Texto completo  Resumo

7. Detterbeck F, Parsons A. Thymic tumors: a review of current diagnosis, classification, and treatment. In: Patterson GA, Cooper JD, Deslauriers J, et al, eds. Thoracic and esophageal surgery, 3rd edition. Philadelphia, PA: Elsevier; 2008:1589-614.

8. Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg. 2004 May;77(5):1860-9.Texto completo  Resumo

9. Bolodár A, Török O, Szabó M, et al. Ruling out fetal Sanfilippo's syndrome (mucopolysaccharidosis IIIA) in the first trimester of pregnancy [in Hungarian]. Orv Hetil. 1989 Jan 29;130(5):233-4. Resumo

10. Suadjian J, Enriquez P, Silverstein MN, et al. The spectrum of diseases associated with thymoma: coincidence or syndrome? Arch Intern Med. 1974;154:374-379. Resumo

11. Cugell DW, Kamp DW. Asbestos and the pleura: a review. Chest. 2004;125:1103-1117. Resumo

12. Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer. 2002 Feb 1;94(3):624-32.Texto completo  Resumo

13. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg. 2003;75:878-885. Resumo

14. Filosso PL, Actis Dato GM, Ruffini E, et al. Multidisciplinary treatment of advanced thymic neuroendocrine carcinoma (carcinoid): report of a successful case and review of the literature. J Thorac Cardiovasc Surg. 2004;127:1215-1219. Resumo

15. Wightman SC, Shrager JB. Non-myasthenia gravis immune syndromes and the thymus: is there a role for thymectomy? Thorac Surg Clin. 2019 May;29(2):215-25. Resumo

16. Zhao J, Bhatnagar V, Ding L, et al. A systematic review of paraneoplastic syndromes associated with thymoma: treatment modalities, recurrence, and outcomes in resected cases. J Thorac Cardiovasc Surg. 2020 Jul;160(1):306-314.e14.Texto completo  Resumo

17. Carter BW, Marom EM, Detterbeck FC. Approaching the patient with an anterior mediastinal mass: a guide for clinicians. J Thorac Oncol. 2014 Sep;9(9 suppl 2):S102-9.Texto completo  Resumo

18. Phan AT, Öberg K, Choi J, et al. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus). Pancreas. 2010;39:784-98.Texto completo  Resumo

19. Kattach H, Hasan S, Clelland C, et al. Seeding of stage I thymoma into the chest wall 12 years after needle biopsy. Ann Thorac Surg. 2005 Jan;79(1):323-4.Texto completo  Resumo

20. Nagasaka T, Nakashima N, Nunome H. Needle tract implantation of thymoma after transthoracic needle biopsy. J Clin Pathol. 1993 Mar;46(3):278-9.Texto completo  Resumo

21. Byrd CT, Trope WL, Bhandari P, et al. Positron emission tomography/computed tomography differentiates resectable thymoma from anterior mediastinal lymphoma. J Thorac Cardiovasc Surg. 2022 Apr 1:S0022-5223(22)00367-1. Resumo

22. Drachman DB. Myasthenia gravis. N Engl J Med. 1994;330:1797-1810. Resumo

23. Wudel LJ Jr, Nesbitt JC. Superior vena cava syndrome. Curr Treat Options Oncol. 2001 Feb;2(1):77-91. Resumo

24. Marom EM. Imaging thymoma. J Thorac Oncol. 2010;5(suppl 4):296S-303S. Resumo

25. Inaoka T, Takahashi K, Mineta M, et al. Thymic hyperplasia and thymus gland tumors: differentiation with chemical shift MR imaging. Radiology. 2007;243:869-876. Resumo

26. Shin KE, Yi CA, Kim TS, et al. Diffusion-weighted MRI for distinguishing non-neoplastic cysts from solid masses in the mediastinum: problem-solving in mediastinal masses of indeterminate internal characteristics on CT. Eur Radiol. 2014 Mar;24(3):677-84. Resumo

27. Kitami A, Sano F, Ohashi S, et al. The usefulness of positron-emission tomography findings in the management of anterior mediastinal tumors. Ann Thorac Cardiovasc Surg. 2017 Feb 20;23(1):26-30.Texto completo  Resumo

28. Luzzi L, Campione A, Gorla A, et al. Role of fluorine-flurodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of anterior mediastinal masses. Eur J Cardiothorac Surg. 2009 Sep;36(3):475-9.Texto completo  Resumo

29. Amin M, Edge B, Greene F, et al; American Joint Commission on Cancer. AJCC cancer staging manual. 8th ed. New York, NY: Springer International Publishing; 2017.

30. Howard FM Jr, Lennon VA, Finley J, et al. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Ann N Y Acad Sci. 1987 Aug;505(1):526-38. Resumo

31. Zekeridou A, McKeon A, Lennon VA. Frequency of synaptic autoantibody accompaniments and neurological manifestations of thymoma. JAMA Neurol. 2016 Jul 1;73(7):853-9.Texto completo  Resumo

32. Maher MM, Shepard JA. Imaging of thymoma. Semin Thorac Cardiovasc Surg. 2005;17:12-19. Resumo

33. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485-2492. Resumo

34. Masaoka A, Yamakawa Y, Niwa H, et al. Thymectomy and malignancy. Eur J Cardiothorac Surg. 1994;8:251-253. Resumo

35. Masaoka A. Staging system of thymoma. J Thorac Oncol. 2010;5(suppl 4):304S-312S. Resumo

36. Cancer Care Ontario. Surgical, radiation, and systemic treatments of patients with thymic epithelial tumours. March 2022 [internet publication].Texto completo

37. Ettinger DS, Akerley W, Bepler G, et al; National Comprehensive Cancer Network. Thymic malignancies. J Natl Compr Canc Netw. 2010;8:1302-1315.Texto completo  Resumo

38. Khorfan R, Bharat A, Odell DD. Management and long-term outcomes of advanced stage thymoma in the United States. Ann Thorac Surg. 2021 Jan;111(1):223-30.Texto completo  Resumo

39. Park S, Park IK, Kim YT, et al. Comparison of neoadjuvant chemotherapy followed by surgery to upfront surgery for thymic malignancy. Ann Thorac Surg. 2019 Feb;107(2):355-62.Texto completo  Resumo

40. Yamada Y, Yoshino I, Nakajima J, et al. Surgical outcomes of patients with stage III thymoma in the Japanese nationwide database. Ann Thorac Surg. 2015 Sep;100(3):961-7.Texto completo  Resumo

41. Leuzzi G, Rocco G, Ruffini E, et al. Multimodality therapy for locally advanced thymomas: a propensity score-matched cohort study from the European Society of Thoracic Surgeons Database. J Thorac Cardiovasc Surg. 2016 Jan;151(1):47-57.e1.Texto completo  Resumo

42. Korst RJ, Bezjak A, Blackmon S, et al. Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial. J Thorac Cardiovasc Surg. 2014 Jan;147(1):36-44, 46.e1.Texto completo  Resumo

43. Davenport E, Malthaner RA. The role of surgery in the management of thymoma: a systematic review. Ann Thorac Surg. 2008;86:673-684. Resumo

44. Nakagawa K, Yokoi K, Nakajima J, et al. Is thymomectomy alone appropriate for stage I (T1N0M0) thymoma? Results of a propensity-score analysis. Ann Thorac Surg. 2016 Feb;101(2):520-6.Texto completo  Resumo

45. Voulaz E, Veronesi G, Infante M, et al. Radical thymectomy versus conservative thymomectomy in the surgical treatment of thymic malignancies. J Thorac Dis. 2018 Jul;10(7):4127-4136.Texto completo  Resumo

46. Tseng YC, Hsieh CC, Huang HY, et al. Is thymectomy necessary in nonmyasthenic patients with early thymoma? J Thorac Oncol. 2013 Jul;8(7):952-8.Texto completo  Resumo

47. Nakagawa K, Asamura H, Sakurai H, et al. Does the mode of surgical resection affect the prognosis/recurrence in patients with thymoma? J Surg Oncol. 2014 Mar;109(3):179-83. Resumo

48. Gu Z, Fu J, Shen Y, et al. Thymectomy versus tumor resection for early-stage thymic malignancies: a Chinese Alliance for Research in Thymomas (ChART) retrospective database analysis [in Chinese]. Zhongguo Fei Ai Za Zhi. 2016 Jul 20;19(7):459-64. Resumo

49. Narm KS, Lee CY, Do YW, et al. Limited thymectomy as a potential alternative treatment option for early-stage thymoma: a multi-institutional propensity-matched study. Lung Cancer. 2016 Nov;101:22-7. Resumo

50. Voulaz E, Perroni G, Russo A, et al. Thymomectomy versus complete thymectomy in early-stage non-myasthenic thymomas: a multicentric propensity score-matched study. Interact Cardiovasc Thorac Surg. 2022 Jun 15;35(1):ivac167.Texto completo  Resumo

51. Yang CJ, Hurd J, Shah SA, et al. A national analysis of open versus minimally invasive thymectomy for stage I to III thymoma. J Thorac Cardiovasc Surg. 2020 Aug;160(2):555-567.e15.Texto completo  Resumo

52. Friedant AJ, Handorf EA, Su S, et al. Minimally invasive versus open thymectomy for thymic malignancies: systematic review and meta-analysis. J Thorac Oncol. 2016 Jan;11(1):30-8.Texto completo  Resumo

53. Manoly I, Whistance RN, Sreekumar R, et al. Early and mid-term outcomes of trans-sternal and video-assisted thoracoscopic surgery for thymoma. Eur J Cardiothorac Surg. 2014 Jun;45(6):e187-93.Texto completo  Resumo

54. Sakamaki Y, Oda T, Kanazawa G, et al. Intermediate-term oncologic outcomes after video-assisted thoracoscopic thymectomy for early-stage thymoma. J Thorac Cardiovasc Surg. 2014 Oct;148(4):1230-7.e1.Texto completo  Resumo

55. Marulli G, Comacchio GM, Schiavon M, et al. Comparing robotic and trans-sternal thymectomy for early-stage thymoma: a propensity score-matching study. Eur J Cardiothorac Surg. 2018 Sep 1;54(3):579-84.Texto completo  Resumo

56. Geraci TC, Ferrari-Light D, Pozzi N, et al. Midterm results for robotic thymectomy for malignant disease. Ann Thorac Surg. 2021 May;111(5):1675-81.Texto completo  Resumo

57. Marcuse F, Hochstenbag M, De Baets MHV, et al. Robotic thymectomy for thymomas: a retrospective follow-up study in the Netherlands. Ann Thorac Surg. 2022 Nov;114(5):1886-94.Texto completo  Resumo

58. Li XK, Xu Y, Cong ZZ, et al. Comparison of the progression-free survival between robot-assisted thymectomy and video-assisted thymectomy for thymic epithelial tumors: a propensity score matching study. J Thorac Dis. 2020 Aug;12(8):4033-43.Texto completo  Resumo

59. Shen C, Li J, Li J, et al. Robot-assisted thoracic surgery versus video-assisted thoracic surgery for treatment of patients with thymoma: a systematic review and meta-analysis. Thorac Cancer. 2022 Jan;13(2):151-61.Texto completo  Resumo

60. Mangi AA, Wright CD, Allan JS, et al. Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg. 2002;74:1033-1037. Resumo

61. Korst RJ, Kansler AL, Christos PJ, et al. Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. Ann Thorac Surg. 2009;87:1641-1647. Resumo

62. Falkson CB, Vella ET, Ellis PM, et al. Surgical, radiation, and systemic treatments of patients with thymic epithelial tumors: a clinical practice guideline. J Thorac Oncol. 2022 Nov;17(11):1258-75.Texto completo  Resumo

63. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: thymomas and thymic carcinomas [internet publication].Texto completo

64. Giannopoulou A, Gkiozos I, Harrington KJ, et al. Thymoma and radiation therapy: a systematic review of medical treatment. Expert Rev Anticancer Ther. 2013;13:759-766. Resumo

65. Chun SG, Rimner A, Amini A, et al. American radium society appropriate use criteria for radiation therapy in the multidisciplinary management of thymic carcinoma. JAMA Oncol. 2023 Jul 1;9(7):971-80. Resumo

66. Venuta F, Rendina EA, Longo F, et al. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg. 2003;76:1866-1872. Resumo

67. Huang J, Rizk NP, Travis WD, et al. Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg. 2007;134:1477-1484. Resumo

68. Loehrer PJ, Jiroutek M, Aisner S, et al. Combined etoposide, ifosfamide and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer. 2001;91:2010-2015. Resumo

69. Riely GJ, Huang J. Induction therapy for locally advanced thymoma. J Thorac Oncol. 2010;5(suppl 4):323S-326S. Resumo

70. Lemma GL, Lee JW, Aisner SC, et al. Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol. 2011 May 20;29(15):2060-5.Texto completo  Resumo

71. Wright CD, Choi NC, Wain JC, et al. Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors. Ann Thorac Surg. 2008;85:385-389. Resumo

72. Loehrer PJ Sr, Chen M, Kim K, et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol. 1997;15:3093-3099. Resumo

73. Wright CD, Wain JC, Wong DR, et al. Predictors of recurrence in thymic tumors: importance of invasion, World Health Organization histology and size. J Thorac Cardiovasc Surg. 2005;130:1413-1421. Resumo

74. Huang J, Rizk NP, Travis WD. Comparison of patterns of relapse in thymic carcinoma and thymoma. J Thorac Cardiovasc Surg. 2009;138:26-31. Resumo

75. Schmitt J, Loehrer PJ. The role of chemotherapy in advanced thymoma. J Thorac Oncol. 2010;5(suppl 4):357S-360S. Resumo

76. Palmieri G, Buonerba C, Ottaviano M, et al. Capecitabine plus gemcitabine in thymic epithelial tumors: final analysis of a Phase II trial. Future Oncol. 2014 Nov;10(14):2141-7. Resumo

77. Zucali PA, De Pas T, Palmieri G, et al. Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy. J Clin Oncol. 2018 Feb 1;36(4):342-9.Texto completo  Resumo

78. Thomas A, Rajan A, Berman A, et al. Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial. Lancet Oncol. 2015 Feb;16(2):177-86. Resumo

79. Sato J, Satouchi M, Itoh S, et al. Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial. Lancet Oncol. 2020 Jun;21(6):843-50. Resumo

80. Wright CD. Pleuropneumonectomy for the treatment of Masaoka stage IVA thymoma. Ann Thorac Surg. 2006;82:1234-1239. Resumo

81. Eng TY, Thomas CR. Radiation therapy in the management of thymic tumors. Semin Thorac Cardiovasc Surg. 2005;17:32-40. Resumo

82. Lucchi M, Mussi A. Surgical treatment of recurrent thymomas. J Thorac Oncol. 2010;5(suppl 4):348S-351S. Resumo

83. Cho J, Kim HS, Ku BM, et al. Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial. J Clin Oncol. 2019 Aug 20;37(24):2162-70. Resumo

84. Giaccone G, Kim C, Thompson J, et al. Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study. Lancet Oncol. 2018 Mar;19(3):347-55. Resumo

85. Skeie GO, Apostolski S, Evoli A, et al. Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol. 2010;17:893-902. Resumo

86. Okereke IC, Kesler KA, Morad MH, et al. Prognostic indicators after surgery for thymoma. Ann Thorac Surg. 2010 Apr;89(4):1071-7; discussion 1077-9.Texto completo  Resumo

87. Rena O, Papalia E, Maggi G, et al. World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer. 2005 Oct;50(1):59-66. Resumo

88. Kondo K, Yoshizawa K, Tsuyuguchi M, et al. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg. 2004 Apr;77(4):1183-8.Texto completo  Resumo

89. Yokoyama S, Miyoshi H. Thymic tumors and immune checkpoint inhibitors. J Thorac Dis. 2018 May;10(suppl 13):S1509-15.Texto completo  Resumo

90. Rajan A, Heery CR, Thomas A, et al. Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma. J Immunother Cancer. 2019 Oct 21;7(1):269.Texto completo  Resumo

91. Kang SY, Lee JS, Choi JC, Kang JH. Myasthenia gravis appearing after thymectomy: a case report and review of the literature. J Clin Neurol. 2007;3:158-160.Texto completo  Resumo

92. Welsh JS, Wilkins KB, Green R, et al. Association between thymoma and second neoplasms. JAMA. 2000;283:1142-1143. Resumo